Device Trial Radar · NCT05317728
Clinical Study of a Fluid Accommodating Intraocular Lens (IOL) Design
Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
175
Actual
Start
Mar 31, 2023
Primary completion
Nov 2026
Study completion Nov 2026
Sponsor
- Lead sponsor
- Alcon ResearchNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 8, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical study is to evaluate the surgical, refractive, and visual outcomes with implantation of an investigational intraocular lens (IOL).
Conditions
- Cataract
Interventions
BAL-FAIOL IOLDevice
Investigational implantable medical device intended for long-term use over the lifetime of the cataract subject
Monofocal IOLDevice
Commercially available implantable medical device intended for long-term use over the lifetime of the cataract subject
Cataract surgeryProcedure
Phacoemulsification with a clear cornea incision
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Photopic Monocular Best Corrected Distance Visual Acuity (BCDVA) (4 meters)Time frame: Month 6 post second eye implantation
- Cumulative Adverse Events, including Secondary Surgical Interventions (SSIs)Time frame: Up to Year 1
- Cumulative Adverse Events, including Secondary Surgical Interventions (SSIs) - Cohort 2Time frame: Up to Year 1
Locations
6 sites in 4 countries. Site status is shown where the registry gives one.
Clinica 20/20
San José, Costa Rica
Laser Center SA
Santo Domingo, Dominican Republic
Asociación Para Evitar la Ceguera en México
Mexico City, Mexico
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.